Posts Tagged


Mar 2021

Cambridge Science Festival / Anne Phelan

Join BenevolentAI’s Chief Scientific Officer at Cambridge Science Festival where she will be speaking about Data science, AI and their potential to transform the discovery and development of medicines.
Mar 2021

Wired Health w/ Joanna Shields

Join BenevolentAI’s CEO Joanna Shields at Wired Health where she will be speaking about forging new frontiers in drug discovery by uniting human and artificial intelligence
Feb 2021

LSX World Congress w/ Jackie Hunter

Join Jackie Hunter at the LSX World Congress where she will discuss AI in drug discovery and development in a panel alongside leaders from Atomwise, Arctoris, Sensyne Health.
Jan 2021

ACTT-2 trial results published in the New England Journal of Medicine validate baricitinib’s efficacy in combination with remdesivir in hospitalised COVID-19 patients

Peer-reviewed data from the ACTT-2 further validate BenevolentAI’s hypothesis for baricitinib as a potential COVID-19 treatment.